Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nonstructural protein 4A (NS4A) is a small, hydrophobic transmembrane protein essential for the life cycle of viruses in the Flaviviridae family, most notably Hepatitis C virus (HCV) and various Flaviviruses such as Dengue and Zika [1, 3]. In HCV, NS4A functions primarily as a critical cofactor for the NS3 serine protease, anchoring the NS3/4A complex to the endoplasmic reticulum membrane and significantly enhancing its proteolytic activity [3, 8]. This complex is responsible for the essential cleavage of the viral polyprotein into functional units, making it a premier target for direct-acting antiviral (DAA) therapies [5, 8]. Beyond its role as a cofactor, NS4A is involved in remodeling host cell membranes to form replication organelles and antagonizing the host's innate immune response by inhibiting interferon signaling [1, 11]. Clinically, numerous NS3/4A protease inhibitors have been approved for the treatment of chronic Hepatitis C, though the emergence of resistance-associated substitutions remains a significant challenge [6, 9]. Research also explores NS4A as a standalone target for other flaviviral infections where it plays pivotal roles in pathogenesis and viral assembly [1, 2].
Inhibition of the NS3/4A serine protease complex, preventing the cleavage of the viral polyprotein into functional nonstructural proteins required for viral replication.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nonstructural protein 4A (NS4A) (NS4A).